HB Investment

Total investments

109

Average round size

5M

Portfolio companies

96

Rounds per year

4.36

Lead investments

4

Follow on index

0.12

Exits

3

Areas of investment
BiotechnologySoftwareFinancial ServicesInformation TechnologyArtificial IntelligenceHealth CareAppsManufacturingMedicalPharmaceutical

Summary

The leading representative office of defined VC is situated in the Seoul. The fund was located in Asia if to be more exact in South Korea.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the HB Investment, startups are often financed by KB Investment, Softbank Ventures Asia, Shinhan Capital. The meaningful sponsors for the fund in investment in the same round are KB Investment, TL Asset Management, Smilegate Investment. In the next rounds fund is usually obtained by Murex Partners, Bass Investment, Shinhan Bank.

Besides them, we counted 2 critical employees of this fund in our database.

The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Medical. Among the various public portfolio startups of the fund, we may underline True Balance, Uberple, Siksin The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea.

Show more

Investments analytics

Analytics

Total investments
109
Lead investments
4
Exits
3
Rounds per year
4.36
Follow on index
0.12
Investments by industry
  • Biotechnology (22)
  • Software (18)
  • Medical (15)
  • Health Care (15)
  • Pharmaceutical (14)
  • Show 129 more
Investments by region
  • South Korea (96)
  • Singapore (2)
  • India (1)
  • Philippines (2)
  • United States (3)
  • Show 3 more
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
8M
Group Appearance index
0.61
Avg. company exit year
6

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Oncosoft 01 Jan 2021 Software, Health Diagnostics, Software Engineering Seed Seoul, Seoul-t'ukpyolsi, South Korea
Techlabs 07 Jul 2021 Artificial Intelligence, Digital Marketing Early Stage Venture 5M Seoul, Seoul-t'ukpyolsi, South Korea
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.